Cardiac Catheters and Guidewires Market - Global Cardiac Catheters and Guidewires Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2023-2030 -

Description

Global Cardiac Catheters and Guidewires Market Set to Reach $22.9 Billion by 2030: Strong Growth Expected with an 8% Expansion.

The global cardiac catheters and guidewires market is poised for significant growth, with projections indicating a surge from the $13.2 billion recorded in 2022 to a substantial $22.9 billion by 2030. Fairfield Market Research's latest report provides a comprehensive analysis of this dynamic market, highlighting key growth drivers, emerging trends, and the competitive landscape.

Key Trends Fueling Growth in the Cardiac Catheters and Guidewires Market

Increasing Demand from Hospitals and Clinics: A key trend driving the growth of the cardiac catheters and guidewires market is the rising demand from hospitals and clinics. Cardiovascular catheters play a vital role in the diagnosis and treatment of cardiovascular diseases, enabling minimally invasive procedures that reduce patient discomfort and recovery times. These catheters are indispensable in modern cardiology, driving their adoption and market expansion.

Hospitals as Key Users: Hospitals have emerged as the primary users of cardiac catheters due to their pivotal role in complex cardiac procedures. Hospitals provide comprehensive cardiovascular care with skilled medical professionals and advanced technologies, thereby increasing the demand for cardiac catheters and facilitating their widespread adoption.

Challenges and Barriers in the Market

Limited Adoption of Intravascular Ultrasound (IVUS) Catheters: The minimal use of IVUS catheters in developing countries presents a challenge in the cardiac catheters and guidewires market. Limited access, infrastructure, and awareness hinder the adoption of advanced IVUS-guided procedures, impacting market growth. Addressing these barriers requires increased healthcare investments, training, and awareness campaigns in developing regions.

Lack of Recycling Infrastructure: The less developed recycling infrastructure poses a challenge in the cardiac catheters and guidewires market. As sustainability gains importance, the lack of effective recycling options for catheters can lead to environmental concerns and disposal issues, affecting market dynamics and prompting the need for eco-friendly solutions.

Key Growth Determinants

Rising Prevalence of Cardiovascular Diseases (CVDs): The increasing prevalence of cardiovascular diseases (CVDs) is a significant driver of the cardiac catheters and guidewires market. CVDs, including heart disease and strokes, remain the leading global cause of death. Cardiac catheters play a pivotal role in diagnosing and treating these conditions, enabling minimally invasive procedures that reduce the need for open-heart surgeries.

Favorable Reimbursement Policies for Coronary Intervention Procedures: Favorable reimbursement policies for coronary intervention procedures are a key driver of the cardiac catheters and guidewires market. These policies make cardiac catheterization procedures more accessible and affordable, alleviating the financial burden on patients and healthcare facilities.

Major Growth Barriers

Limited Use of IVUS Catheters in Developing Countries: The minimal use of Intravascular Ultrasound (IVUS) catheters in developing countries presents a challenge in the cardiac catheters and guidewires market. Increased healthcare spending, education, and awareness efforts are necessary to overcome this challenge and expand the use of IVUS catheters.

Less Skilled Healthcare Professionals: A shortage of qualified healthcare professionals experienced in catheterization operations poses challenges, particularly in low- and middle-income nations. Investment in medical education, training programs, and establishing centers of excellence is essential to address this barrier and improve patient access to catheterization procedures.

Key Trends and Opportunities to Watch

Innovative Biomaterials: Innovative materials, including bioresorbable polymers and biocompatible coatings, are a prominent trend in the cardiac catheters and guidewires market. These materials aim to improve the overall performance, safety, and patient outcomes of catheter-based procedures, positioning them as a key trend in the market.

Adoption of Robotics Technology: Robotics is a significant technology trend in the cardiac catheters and guidewires market. Smaller and more precise robotic systems enable remote-controlled catheterization procedures, expanding access to specialized care and enhancing procedural precision.

Focus on Development of Bioresorbable Stents: Bioresorbable stents are a notable technology trend in the market. Research is directed toward enhancing their mechanical properties and drug-eluting capabilities, aiming to create stents that offer optimal performance while gradually resorbing into the body, reducing long-term complications.

Regional Frontrunners

North America: North America leads the market due to its robust healthcare infrastructure, high prevalence of cardiovascular diseases, favorable reimbursement policies, strong research and development activities, and the presence of key market players.

Asia Pacific: The Asia Pacific region is expected to witness significant growth, driven by the rising prevalence of cardiovascular diseases, expanding healthcare infrastructure, increasing healthcare investments, and a large and aging population with cardiovascular risk factors.

Leading Companies in the Global Cardiac Catheters and Guidewires Market:

Boston Scientific Corporation
Medtronic PLC
Abbott Laboratories
Johnson & Johnson
Terumo Corporation
Braun Melsungen AG
Edwards Lifesciences Corporation
Cardinal Health, Inc.

Cook Medical Inc.
Biotronik SE & Co. KG
Teleflex Incorporated
AngioDynamics, Inc.
Oscor Inc.
Penumbra, Inc.
ASAHI INTECC Co., Ltd.

1. Executive Summary

1.1. Global Cardiac Catheters and Guidewires Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value, 2022
1.5. Analyst Recommendations

2. Market Overview

2.1. Market Definitions and Segmentations
2.2. Market Dynamics
- 2.2.1. Drivers
- 2.2.2. Restraints
- 2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. Porter's Five Forces Analysis
2.5. Covid-19 Impact Analysis
- 2.5.1. Supply
- 2.5.2. Demand
2.6. Impact of Ukraine-Russia Conflict
2.7. Economic Overview
- 2.7.1. World Economic Projections
2.8. PESTLE Analysis

3. Global Cardiac Catheters and Guidewires Market Outlook, 2018 - 2030

3.1. Global Cardiac Catheters and Guidewires Market Outlook, by Product, Value (US$ Bn), 2018 - 2030
- 3.1.1. Key Highlights
  - 3.1.1.1. Cardiac Catheters
  - 3.1.1.2. Cardiac Guidewires
3.2. Global Cardiac Catheters and Guidewires Market Outlook, by End-use, Value (US$ Bn), 2018 - 2030
- 3.2.1. Key Highlights
  - 3.2.1.1. Hospitals
  - 3.2.1.2. Clinics
  - 3.2.1.3. Ambulatory Surgical Centers
3.3. Global Cardiac Catheters and Guidewires Market Outlook, by Region, Value (US$ Bn), 2018 - 2030
- 3.3.1. Key Highlights
  - 3.3.1.1. North America
  - 3.3.1.2. Europe
  - 3.3.1.3. Asia Pacific
  - 3.3.1.4. Latin America
  - 3.3.1.5. Middle East & Africa

4. North America Cardiac Catheters and Guidewires Market Outlook, 2018 - 2030

4.1. North America Cardiac Catheters and Guidewires Market Outlook, by Product, Value (US$ Bn), 2018 - 2030
- 4.1.1. Key Highlights
  - 4.1.1.1. Cardiac Catheters
  - 4.1.1.2. Cardiac Guidewires
4.2. North America Cardiac Catheters and Guidewires Market Outlook, by End-use, Value (US$ Bn), 2018 - 2030
- 4.2.1. Key Highlights
  - 4.2.1.1. Hospitals
  - 4.2.1.2. Clinics
  - 4.2.1.3. Ambulatory Surgical Centers
- 4.2.2. BPS Analysis/Market Attractiveness Analysis
4.3. North America Cardiac Catheters and Guidewires Market Outlook, by Country, Value (US$ Bn), 2018 - 2030
- 4.3.1. Key Highlights
  - 4.3.1.1. U.S. Cardiac Catheters and Guidewires Market Product, Value (US$ Bn), 2018 - 2030
  - 4.3.1.2. U.S. Cardiac Catheters and Guidewires Market End-use, Value (US$ Bn), 2018 - 2030
  - 4.3.1.3. Canada Cardiac Catheters and Guidewires Market Product, Value (US$ Bn), 2018 - 2030
  - 4.3.1.4. Canada Cardiac Catheters and Guidewires Market End-use, Value (US$ Bn), 2018 - 2030
- 4.3.2. BPS Analysis/Market Attractiveness Analysis

5. Europe Cardiac Catheters and Guidewires Market Outlook, 2018 - 2030

5.1. Europe Cardiac Catheters and Guidewires Market Outlook, by Product, Value (US$ Bn), 2018 - 2030
- 5.1.1. Key Highlights
  - 5.1.1.1. Cardiac Catheters
  - 5.1.1.2. Cardiac Guidewires
5.2. Europe Cardiac Catheters and Guidewires Market Outlook, by End-use, Value (US$ Bn), 2018 - 2030
- 5.2.1. Key Highlights
  - 5.2.1.1. Hospitals
  - 5.2.1.2. Clinics
  - 5.2.1.3. Ambulatory Surgical Centers
- 5.2.2. BPS Analysis/Market Attractiveness Analysis
5.3. Europe Cardiac Catheters and Guidewires Market Outlook, by Country, Value (US$ Bn), 2018 - 2030
- 5.3.1. Key Highlights
  - 5.3.1.1. Germany Cardiac Catheters and Guidewires Market Product, Value (US$ Bn), 2018 - 2030
  - 5.3.1.2. Germany Cardiac Catheters and Guidewires Market End-use, Value (US$ Bn), 2018 - 2030
  - 5.3.1.3. U.K. Cardiac Catheters and Guidewires Market Product, Value (US$ Bn), 2018 - 2030
  - 5.3.1.4. U.K. Cardiac Catheters and Guidewires Market End-use, Value (US$ Bn), 2018 - 2030
  - 5.3.1.5. France Cardiac Catheters and Guidewires Market Product, Value (US$ Bn), 2018 - 2030
  - 5.3.1.6. France Cardiac Catheters and Guidewires Market End-use, Value (US$ Bn), 2018 - 2030
  - 5.3.1.7. Italy Cardiac Catheters and Guidewires Market Product, Value (US$ Bn), 2018 - 2030
  - 5.3.1.8. Italy Cardiac Catheters and Guidewires Market End-use, Value (US$ Bn), 2018 - 2030
  - 5.3.1.9. Turkey Cardiac Catheters and Guidewires Market Product, Value (US$ Bn), 2018 - 2030
  - 5.3.1.10. Turkey Cardiac Catheters and Guidewires Market End-use, Value (US$ Bn), 2018 - 2030
  - 5.3.1.11. Russia Cardiac Catheters and Guidewires Market Product, Value (US$ Bn), 2018 - 2030
  - 5.3.1.12. Russia Cardiac Catheters and Guidewires Market End-use, Value (US$ Bn), 2018 - 2030
  - 5.3.1.13. Rest of Europe Cardiac Catheters and Guidewires Market Product, Value (US$ Bn), 2018 - 2030
  - 5.3.1.14. Rest of Europe Cardiac Catheters and Guidewires Market End-use, Value (US$ Bn), 2018 - 2030
- 5.3.2. BPS Analysis/Market Attractiveness Analysis

6. Asia Pacific Cardiac Catheters and Guidewires Market Outlook, 2018 - 2030

6.1. Asia Pacific Cardiac Catheters and Guidewires Market Outlook, by Product, Value (US$ Bn), 2018 - 2030
- 6.1.1. Key Highlights
  - 6.1.1.1. Cardiac Catheters
  - 6.1.1.2. Cardiac Guidewires
6.2. Asia Pacific Cardiac Catheters and Guidewires Market Outlook, by End-use, Value (US$ Bn), 2018 - 2030
- 6.2.1. Key Highlights
  - 6.2.1.1. Hospitals
  - 6.2.1.2. Clinics
  - 6.2.1.3. Ambulatory Surgical Centers
- 6.2.2. BPS Analysis/Market Attractiveness Analysis
6.3. Asia Pacific Cardiac Catheters and Guidewires Market Outlook, by Country, Value (US$ Bn), 2018 - 2030
- 6.3.1. Key Highlights
  - 6.3.1.1. China Cardiac Catheters and Guidewires Market Product, Value (US$ Bn), 2018 - 2030
  - 6.3.1.2. China Cardiac Catheters and Guidewires Market by End-use, Value (US$ Bn), 2018 - 2030
  - 6.3.1.3. Japan Cardiac Catheters and Guidewires Market Product, Value (US$ Bn), 2018 - 2030
  - 6.3.1.4. Japan Cardiac Catheters and Guidewires Market End-use, Value (US$ Bn), 2018 - 2030
  - 6.3.1.5. South Korea Cardiac Catheters and Guidewires Market Product, Value (US$ Bn), 2018 - 2030
  - 6.3.1.6. South Korea Cardiac Catheters and Guidewires Market End-use, Value (US$ Bn), 2018 - 2030
  - 6.3.1.7. India Cardiac Catheters and Guidewires Market Product, Value (US$ Bn), 2018 - 2030
  - 6.3.1.8. India Cardiac Catheters and Guidewires Market End-use, Value (US$ Bn), 2018 - 2030
  - 6.3.1.9. Southeast Asia Cardiac Catheters and Guidewires Market Product, Value (US$ Bn), 2018 - 2030
  - 6.3.1.10. Southeast Asia Cardiac Catheters and Guidewires Market End-use, Value (US$ Bn), 2018 - 2030
  - 6.3.1.11. Rest of Asia Pacific Cardiac Catheters and Guidewires Market Product, Value (US$ Bn), 2018 - 2030
  - 6.3.1.12. Rest of Asia Pacific Cardiac Catheters and Guidewires Market End-use, Value (US$ Bn), 2018 - 2030
- 6.3.2. BPS Analysis/Market Attractiveness Analysis

7. Latin America Cardiac Catheters and Guidewires Market Outlook, 2018 - 2030

7.1. Latin America Cardiac Catheters and Guidewires Market Outlook, by Product, Value (US$ Bn), 2018 - 2030
- 7.1.1. Key Highlights
  - 7.1.1.1. Cardiac Catheters
  - 7.1.1.2. Cardiac Guidewires
7.2. Latin America Cardiac Catheters and Guidewires Market Outlook, by End-use, Value (US$ Bn), 2018 - 2030
- 7.2.1. Key Highlights
  - 7.2.1.1. Hospitals
  - 7.2.1.2. Clinics
  - 7.2.1.3. Ambulatory Surgical Centers
- 7.2.2. BPS Analysis/Market Attractiveness Analysis
7.3. Latin America Cardiac Catheters and Guidewires Market Outlook, by Country, Value (US$ Bn), 2018 - 2030
- 7.3.1. Key Highlights
  - 7.3.1.1. Brazil Cardiac Catheters and Guidewires Market Product, Value (US$ Bn), 2018 - 2030
  - 7.3.1.2. Brazil Cardiac Catheters and Guidewires Market End-use, Value (US$ Bn), 2018 - 2030
  - 7.3.1.3. Mexico Cardiac Catheters and Guidewires Market Product, Value (US$ Bn), 2018 - 2030
  - 7.3.1.4. Mexico Cardiac Catheters and Guidewires Market End-use, Value (US$ Bn), 2018 - 2030
  - 7.3.1.5. Argentina Cardiac Catheters and Guidewires Market Product, Value (US$ Bn), 2018 - 2030
  - 7.3.1.6. Argentina Cardiac Catheters and Guidewires Market End-use, Value (US$ Bn), 2018 - 2030
  - 7.3.1.7. Rest of Latin America Cardiac Catheters and Guidewires Market Product, Value (US$ Bn), 2018 - 2030
  - 7.3.1.8. Rest of Latin America Cardiac Catheters and Guidewires Market End-use, Value (US$ Bn), 2018 - 2030
- 7.3.2. BPS Analysis/Market Attractiveness Analysis

8. Middle East & Africa Cardiac Catheters and Guidewires Market Outlook, 2018 - 2030

8.1. Middle East & Africa Cardiac Catheters and Guidewires Market Outlook, by Product, Value (US$ Bn), 2018 - 2030
- 8.1.1. Key Highlights
  - 8.1.1.1. Cardiac Catheters
  - 8.1.1.2. Cardiac Guidewires
8.2. Middle East & Africa Cardiac Catheters and Guidewires Market Outlook, by End-use, Value (US$ Bn), 2018 - 2030
- 8.2.1. Key Highlights
  - 8.2.1.1. Hospitals
  - 8.2.1.2. Clinics
  - 8.2.1.3. Ambulatory Surgical Centers
- 8.2.2. BPS Analysis/Market Attractiveness Analysis
8.3. Middle East & Africa Cardiac Catheters and Guidewires Market Outlook, by Country, Value (US$ Bn), 2018 - 2030
- 8.3.1. Key Highlights
  - 8.3.1.1. GCC Cardiac Catheters and Guidewires Market Product, Value (US$ Bn), 2018 - 2030
  - 8.3.1.2. GCC Cardiac Catheters and Guidewires Market End-use, Value (US$ Bn), 2018 - 2030
  - 8.3.1.3. South Africa Cardiac Catheters and Guidewires Market Product, Value (US$ Bn), 2018 - 2030
  - 8.3.1.4. South Africa Cardiac Catheters and Guidewires Market End-use, Value (US$ Bn), 2018 - 2030
  - 8.3.1.5. Egypt Cardiac Catheters and Guidewires Market Product, Value (US$ Bn), 2018 - 2030
  - 8.3.1.6. Egypt Cardiac Catheters and Guidewires Market End-use, Value (US$ Bn), 2018 - 2030
  - 8.3.1.7. Nigeria Cardiac Catheters and Guidewires Market Product, Value (US$ Bn), 2018 - 2030
  - 8.3.1.8. Nigeria Cardiac Catheters and Guidewires Market End-use, Value (US$ Bn), 2018 - 2030
  - 8.3.1.9. Rest of Middle East & Africa Cardiac Catheters and Guidewires Market Product, Value (US$ Bn), 2018 - 2030
  - 8.3.1.10. Rest of Middle East & Africa Cardiac Catheters and Guidewires Market End-use, Value (US$ Bn), 2018 - 2030
- 8.3.2. BPS Analysis/Market Attractiveness Analysis

9. Competitive Landscape

9.1. Capacity vs End-use Heatmap
9.2. Manufacturer vs End-use Heatmap
9.3. Company Market Share Analysis, 2022
9.4. Competitive Dashboard
9.5. Company Profiles
- 9.5.1. Boston Scientific Corporation
  - 9.5.1.1. Company Overview
  - 9.5.1.2. Product Portfolio
  - 9.5.1.3. Financial Overview
  - 9.5.1.4. Business Strategies and Development
- 9.5.2. Medtronic PLC
  - 9.5.2.1. Company Overview
  - 9.5.2.2. Product Portfolio
  - 9.5.2.3. Financial Overview
  - 9.5.2.4. Business Strategies and Development
- 9.5.3. Abbott Laboratories
  - 9.5.3.1. Company Overview
  - 9.5.3.2. Product Portfolio
  - 9.5.3.3. Financial Overview
  - 9.5.3.4. Business Strategies and Development
- 9.5.4. Johnson & Johnson
  - 9.5.4.1. Company Overview
  - 9.5.4.2. Product Portfolio
  - 9.5.4.3. Financial Overview
  - 9.5.4.4. Business Strategies and Development
- 9.5.5. Terumo Corporation
  - 9.5.5.1. Company Overview
  - 9.5.5.2. Product Portfolio
  - 9.5.5.3. Financial Overview
  - 9.5.5.4. Business Strategies and Development
- 9.5.6. Edwards Lifesciences Corporation
  - 9.5.6.1. Company Overview
  - 9.5.6.2. Product Portfolio
  - 9.5.6.3. Financial Overview
  - 9.5.6.4. Business Strategies and Development
- 9.5.7. Cardinal Health, Inc.
  - 9.5.7.1. Company Overview
  - 9.5.7.2. Product Portfolio
  - 9.5.7.3. Financial Overview
  - 9.5.7.4. Business Strategies and Development
- 9.5.8. Cook Medical Inc.
  - 9.5.8.1. Company Overview
  - 9.5.8.2. Product Portfolio
  - 9.5.8.3. Business Strategies and Development
- 9.5.9. Biotronik SE & Co. KG
  - 9.5.9.1. Company Overview
  - 9.5.9.2. Product Portfolio
  - 9.5.9.3. Financial Overview
  - 9.5.9.4. Business Strategies and Development
- 9.5.10. Teleflex Incorporated
  - 9.5.10.1. Company Overview
  - 9.5.10.2. Product Portfolio
  - 9.5.10.3. Financial Overview
  - 9.5.10.4. Business Strategies and Development
- 9.5.11. FlexFilms (USA) Inc
  - 9.5.11.1. Company Overview
  - 9.5.11.2. Product Portfolio
  - 9.5.11.3. Financial Overview
  - 9.5.11.4. Business Strategies and Development
- 9.5.12. Merit Medical Systems, Inc.
  - 9.5.12.1. Company Overview
  - 9.5.12.2. Product Portfolio
  - 9.5.12.3. Financial Overview
  - 9.5.12.4. Business Strategies and Development
- 9.5.13. AngioDynamics, Inc.
  - 9.5.13.1. Company Overview
  - 9.5.13.2. Product Portfolio
  - 9.5.13.3. Financial Overview
  - 9.5.13.4. Business Strategies and Development
- 9.5.14. Biosense Webster, Inc.
  - 9.5.14.1. Company Overview
  - 9.5.14.2. Product Portfolio
  - 9.5.14.3. Financial Overview
  - 9.5.14.4. Business Strategies and Development
- 9.5.15. Oscor Inc.
  - 9.5.15.1. Company Overview
  - 9.5.15.2. Product Portfolio
  - 9.5.15.3. Financial Overview
  - 9.5.15.4. Business Strategies and Development

10. Appendix

10.1. Research Methodology
10.2. Report Assumptions
10.3. Acronyms and Abbreviations